The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Kinetic Characterization of Ribonuclease-Resistant 2′-Modified Hammerhead Ribozymes
Abstract
The incorporation of 2′-fluoro- and 2′-aminonucleotides into a hammerhead ribozyme was accomplished by automated chemical synthesis. The presence of 2′-fluorouridines, 2′-fluorocytidines, or 2′-aminouridines did not appreciably decrease catalytic efficiency. Incorporation of 2′-aminocytidines decreased ribozyme activity approximately by a factor of 20. The replacement of all adenosines with 2′-fluoroadenosines abolished catalysis in the presence of MgCl 2 within the limits of detection, but some activity was retained in the presence of MnCl 2 . This effect on catalysis was localized to a specific group of adenines within the conserved single-stranded region of the ribozyme. The decrease in catalytic efficiency was caused by a decrease in the rate constant; the Michaelis constant was unaltered. The 2′-fluoro and 2′-amino modifications conferred resistance toward ribonuclease degradation. Ribozymes containing 2′-fluoro- or 2′-aminonucleotides at all uridine and cytidine positions were stabilized against degradation in rabbit serum by a factor of at least 10 3 compared to unmodified ribozyme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of Nucleic Acid Structure
(2008) · Elsevier eBooks · doi:10.1016/b978-0-12-369507-9.x5001-8 · Cited by 4,504
Principles of Nucleic Acid Structure
Saenger, W. (1984) · Springer Advanced Texts in Chemistry · doi:10.1007/978-1-4612-5190-3 · Cited by 4,150
Antisense oligonucleotides: a new therapeutic principle
Uhlmann, E., & Peyman, A. (1990) · Chemical Reviews · doi:10.1021/cr00102a001 · Cited by 1,640
Mapping adenines, guanines, and pyrimidines in RNA
Donis-Keller, H., Maxam, A. M., & Gilbert, W. (1977) · Nucleic Acids Research · doi:10.1093/nar/4.8.2527 · Cited by 1,371
A small catalytic oligoribonucleotide
Uhlenbeck, O. C. (1987) · Nature · doi:10.1038/328596a0 · Cited by 930
Sinha, N. D., Biernat, J., McManus, J., & Köster, H. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.11.4539 · Cited by 849
Self-cleavage of plus and minus RNA transcripts of avocado sunblotch viroid
Hutchins, C. J., Rathjen, P. D., Forster, A. C., & Symons, R. H. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.9.3627 · Cited by 585
Scaringe, S. A., Francklyn, C., & Usman, N. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.18.5433 · Cited by 263
Substrate sequence effects on "hammerhead" RNA catalytic efficiency.
Fedor, M. J., & Uhlenbeck, O. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1668 · Cited by 233
Nucleoside conformation is determined by the electronegativity of the sugar substituent
Guschlbauer, W., & Jankowski, K. (1980) · Nucleic Acids Research · doi:10.1093/nar/8.6.1421 · Cited by 204
Cited by
Aptamers as targeted therapeutics: current potential and challenges
Zhou, J., & Rossi, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.199 · Cited by 2,221
Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics
Jayasena, S. D. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.9.1628 · Cited by 2,144
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,588
In Vitro Selection of Functional Nucleic Acids
Wilson, D. S., & Szostak, J. W. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.611 · Cited by 1,206
Analytical applications of aptamers
Tombelli, S., Minunni, M., & Mascini, M. (2005) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2004.11.006 · Cited by 1,017
siRNAs: applications in functional genomics and potential as therapeutics
Dorsett, Y., & Tuschl, T. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1345 · Cited by 909
Electronic Aptamer‐Based Sensors
Willner, I., & Zayats, M. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200604524 · Cited by 818
Ruckman, J., Green, L. S., Beeson, J., Waugh, S., Gillette, W. L., Henninger, D. D., Claesson-Welsh, L., & Janjic, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 744
Aptamers come of age – at last
Bunka, D. H. J., & Stockley, P. G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1458 · Cited by 695
In vivo activity of nuclease-resistant siRNAs
LAYZER, J. M., MCCAFFREY, A. P., TANNER, A. K., HUANG, Z., KAY, M. A., & SULLENGER, B. A. (2004) · RNA · doi:10.1261/rna.5239604 · Cited by 580
Rohloff, J. C., Gelinas, A. D., Jarvis, T. C., Ochsner, U. A., Schneider, D. J., Gold, L., & Janjic, N. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.49 · Cited by 533
Nucleic Acid Selection and the Challenge of Combinatorial Chemistry
Osborne, S. E., & Ellington, A. D. (1997) · Chemical Reviews · doi:10.1021/cr960009c · Cited by 520
RNA aptamers as reversible antagonists of coagulation factor IXa
Rusconi, C. P., Scardino, E., Layzer, J., Pitoc, G. A., Ortel, T. L., Monroe, D., & Sullenger, B. A. (2002) · Nature · doi:10.1038/nature00963 · Cited by 512
The Medicinal Chemistry of Therapeutic Oligonucleotides
Wan, W. B., & Seth, P. P. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00551 · Cited by 429
Aptamers in the Therapeutics and Diagnostics Pipelines
Kaur, H., Bruno, J. G., Kumar, A., & Sharma, T. K. (2018) · Theranostics · doi:10.7150/thno.25958 · Cited by 366
Molecular mechanisms of action of antisense drugs
Crooke, S. T. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00148-7 · Cited by 358
SELEX: Critical factors and optimization strategies for successful aptamer selection
Kohlberger, M., & Gadermaier, G. (2022) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2244 · Cited by 341
An enzyme-linked oligonucleotide assay
Drolet, D. W., Moon-McDermott, L., & Romig, T. S. (1996) · Nature Biotechnology · doi:10.1038/nbt0896-1021 · Cited by 335
MODIFIED OLIGONUCLEOTIDES: Synthesis and Strategy for Users
Verma, S., & Eckstein, F. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.99 · Cited by 315
Self-citationMultivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice
McNamara, J. O., Kolonias, D., Pastor, F., Mittler, R. S., Chen, L., Giangrande, P. H., Sullenger, B., & Gilboa, E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33365 · Cited by 310
Deng, Y., Wang, C. C., Choy, K. W., Du, Q., Chen, J., Wang, Q., Li, L., Chung, T. K. H., & Tang, T. (2014) · Gene · doi:10.1016/j.gene.2013.12.019 · Cited by 301
Engineering RNA for Targeted siRNA Delivery and Medical Application
Guo, P., Coban, O., Snead, N. M., Trebley, J., Hoeprich, S., Guo, S., & Shu, Y. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.008 · Cited by 300
Developing aptamers into therapeutics
White, R. R., Sullenger, B. A., & Rusconi, C. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11325 · Cited by 295
Application of locked nucleic acids to improve aptamer in vivo stability and targeting function
Schmidt, K. S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh862 · Cited by 287
Generation of Species Cross-reactive Aptamers Using “Toggle” SELEX
White, R., Rusconi, C., Scardino, E., Wolberg, A., Lawson, J., Hoffman, M., & Sullenger, B. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0495 · Cited by 284
Green, L. S., Jellinek, D., Bell, C., Beebe, L. A., Feistner, B. D., Gill, S. C., Jucker, F. M., & Janjić, N. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90032-2 · Cited by 284
The Structure, Function and Application of the Hammerhead Ribozyme
Birikh, K. R., Heaton, P. A., & Eckstein, F. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-3-00001.x · Cited by 276
Self-citationAptamers and the next generation of diagnostic reagents
Thiviyanathan, V., & Gorenstein, D. G. (2012) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201200042 · Cited by 275
Nucleic acid aptamers in cancer research, diagnosis and therapy
Ma, H., Liu, J., Ali, M. M., Mahmood, M. A. I., Labanieh, L., Lu, M., Iqbal, S. M., Zhang, Q., Zhao, W., & Wan, Y. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00357h · Cited by 265
Biosensor Recognition Elements
(2008) · Current Issues in Molecular Biology · doi:10.21775/cimb.010.001 · Cited by 264
A Kinetic and Thermodynamic Framework for the Hammerhead Ribozyme Reaction
Hertel, K. J., Herschlag, D., & Uhlenbeck, O. C. (1994) · Biochemistry · doi:10.1021/bi00177a031 · Cited by 264
Nanoparticle–aptamer bioconjugates for cancer targeting
Farokhzad, O. C., Karp, J. M., & Langer, R. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.3.311 · Cited by 256
Detection of pathogens in foods: the current state-of-the-art and future directions
Dwivedi, H. P., & Jaykus, L.-A. (2011) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2010.506430 · Cited by 255
Lipid nanoparticles for short interfering RNA delivery
Leung, A. K. K., Tam, Y. Y. C., & Cullis, P. R. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00004-3 · Cited by 158
Giannaris, P. A., & Damha, M. J. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.20.4742 · Cited by 109
Emerging affinity-based techniques in proteomics
Xie, S., Moya, C., Bilgin, B., Jayaraman, A., & Walton, S. P. (2009) · Expert Review of Proteomics · doi:10.1586/epr.09.74 · Cited by 38
Metadata
- Authors
- Pieken, W. A., Olsen, D. B., Benseler, F., Aurup, H., & Eckstein, F.
- Venue
- Science
- Published
- 1991-07-19
- Volume
- 253
- Issue
- 5017
- Pages
- 314-317
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2048916976
- Cited by
- 463
- References
- 17
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.